These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 21710499

  • 1. YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma.
    Holzmüller R, Mantwill K, Haczek C, Rognoni E, Anton M, Kasajima A, Weichert W, Treue D, Lage H, Schuster T, Schlegel J, Gänsbacher B, Holm PS.
    Int J Cancer; 2011 Sep 01; 129(5):1265-76. PubMed ID: 21710499
    [Abstract] [Full Text] [Related]

  • 2. YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.
    Mantwill K, Naumann U, Seznec J, Girbinger V, Lage H, Surowiak P, Beier D, Mittelbronn M, Schlegel J, Holm PS.
    J Transl Med; 2013 Sep 18; 11():216. PubMed ID: 24044901
    [Abstract] [Full Text] [Related]

  • 3. An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.
    Kostova Y, Mantwill K, Holm PS, Anton M.
    Cancer Gene Ther; 2015 Jan 18; 22(1):30-43. PubMed ID: 25501992
    [Abstract] [Full Text] [Related]

  • 4. Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo.
    Rognoni E, Widmaier M, Haczek C, Mantwill K, Holzmüller R, Gansbacher B, Kolk A, Schuster T, Schmid RM, Saur D, Kaszubiak A, Lage H, Holm PS.
    Cancer Gene Ther; 2009 Oct 18; 16(10):753-63. PubMed ID: 19363467
    [Abstract] [Full Text] [Related]

  • 5. CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
    Kaliberova LN, Krendelchtchikova V, Harmon DK, Stockard CR, Petersen AS, Markert JM, Gillespie GY, Grizzle WE, Buchsbaum DJ, Kaliberov SA.
    Cancer Gene Ther; 2009 Oct 18; 16(10):794-805. PubMed ID: 19363468
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents.
    Mantwill K, Köhler-Vargas N, Bernshausen A, Bieler A, Lage H, Kaszubiak A, Surowiak P, Dravits T, Treiber U, Hartung R, Gansbacher B, Holm PS.
    Cancer Res; 2006 Jul 15; 66(14):7195-202. PubMed ID: 16849566
    [Abstract] [Full Text] [Related]

  • 7. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
    Su BH, Shieh GS, Tseng YL, Shiau AL, Wu CL.
    Oncotarget; 2015 Nov 10; 6(35):38308-26. PubMed ID: 26515462
    [Abstract] [Full Text] [Related]

  • 8. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
    Ulasov IV, Zhu ZB, Tyler MA, Han Y, Rivera AA, Khramtsov A, Curiel DT, Lesniak MS.
    Hum Gene Ther; 2007 Jul 10; 18(7):589-602. PubMed ID: 17630837
    [Abstract] [Full Text] [Related]

  • 9. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.
    Jiang G, Sun C, Li RH, Wei ZP, Zheng JN, Liu YQ.
    J Cancer Res Clin Oncol; 2015 Jan 10; 141(1):75-85. PubMed ID: 25103017
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H, Wei F, Li H, Ji X, Li S, Chen X.
    Int J Mol Med; 2013 Feb 10; 31(2):377-85. PubMed ID: 23229955
    [Abstract] [Full Text] [Related]

  • 12. Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors.
    Post DE, Devi NS, Li Z, Brat DJ, Kaur B, Nicholson A, Olson JJ, Zhang Z, Van Meir EG.
    Clin Cancer Res; 2004 Dec 15; 10(24):8603-12. PubMed ID: 15623644
    [Abstract] [Full Text] [Related]

  • 13. Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo.
    Ulasov IV, Sonabend AM, Nandi S, Khramtsov A, Han Y, Lesniak MS.
    Br J Cancer; 2009 Apr 07; 100(7):1154-64. PubMed ID: 19277041
    [Abstract] [Full Text] [Related]

  • 14. Oncolytic herpes simplex virus mutants exhibit enhanced replication in glioma cells evading temozolomide chemotherapy through deoxyribonucleic acid repair.
    Aghi M, Rabkin S, Martuza RL.
    Clin Neurosurg; 2006 Apr 07; 53():65-76. PubMed ID: 17380741
    [No Abstract] [Full Text] [Related]

  • 15. Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo.
    Alonso MM, Gomez-Manzano C, Jiang H, Bekele NB, Piao Y, Yung WK, Alemany R, Fueyo J.
    Cancer Gene Ther; 2007 Aug 07; 14(8):756-61. PubMed ID: 17557108
    [Abstract] [Full Text] [Related]

  • 16. Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells.
    Czolk R, Schwarz N, Koch H, Schötterl S, Wuttke TV, Holm PS, Huber SM, Naumann U.
    Int J Mol Med; 2019 Oct 07; 44(4):1484-1494. PubMed ID: 31432139
    [Abstract] [Full Text] [Related]

  • 17. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
    Zhang J, Wei F, Wang H, Li H, Qiu W, Ren P, Chen X, Huang Q.
    Cancer Biother Radiopharm; 2010 Aug 07; 25(4):487-95. PubMed ID: 20735209
    [Abstract] [Full Text] [Related]

  • 18. Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.
    Lamfers ML, Grill J, Dirven CM, Van Beusechem VW, Geoerger B, Van Den Berg J, Alemany R, Fueyo J, Curiel DT, Vassal G, Pinedo HM, Vandertop WP, Gerritsen WR.
    Cancer Res; 2002 Oct 15; 62(20):5736-42. PubMed ID: 12384532
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.